end-stage kidney disease Kidney dysfunction, peritoneal dialysis
Conditions
Interventions
Use of Icodextrin dialysate
Sponsors
Hamada Riku
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pediatric peritoneal dialysis patients 2. Age under 18 years at the time of consent 3. Patients who have been 3 months or more since the introduction of peritoneal dialysis 4. Provide written informed consent by legal guardian
Exclusion criteria
Exclusion criteria: 1. Patient within 3 months after peritonitis 2. Patients within 3 months after surgery to operate the peritoneum 3. Intraperitoneal adhesions or compartment syndromes that make it difficult to inject the prescribed injection volume 4. Patients whose attending physicians judged this study to be inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the amount of water removalper body surface area (mL/m2) of Icodextrin dialysate and 2.5% sugar concentration dialysate at 12 hours retention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Comparison of water removal volume (mL / m2) of Icodextrin dialysate and 2.5% sugar concentration dialysate by difference in peritoneal function (peritoneal equilibrium test category) 2. Comparison of water removal volume (mL / m2) of Icodextrin dialysate and 2.5% sugar concentration dialysate at 8 hours retention 3. Comparison of water removal volume (mL / m2) by retention time (8 hours vs. 12 hours) of each dialysate 4. Comparison of solute removal ability and sugar absorption amount with Icodextrin dialysate and 2.5% sugar concentration dialysate | — |
Contacts
Public ContactRiku Hamada
Tokyo metropolitan children's medical center
Outcome results
None listed